Sparrow Pharmaceuticals
Clinical trials sponsored by Sparrow Pharmaceuticals, explained in plain language.
-
New drug aims to tackle diabetes by targeting stress hormone
Disease control Recruiting nowThis phase 2 trial tests clofutriben, a drug that lowers cortisol, in 1500 adults with hard-to-control type 2 diabetes and signs of high cortisol. Participants receive either clofutriben or a placebo daily for 24 weeks. The study measures changes in blood sugar and cortisol level…
Phase: PHASE2 • Sponsor: Sparrow Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Kidney function may affect new drug levels
Knowledge-focused Recruiting nowThis early-stage study looks at how the drug clofutriben is processed in people with moderate kidney impairment compared to those with normal kidneys. Sixteen adults will receive a single dose, and researchers will measure drug levels in the blood. The goal is to see if kidney fu…
Phase: PHASE1 • Sponsor: Sparrow Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC